Literature DB >> 16882063

Fournier's gangrene: report of thirty-three cases and a review of the literature.

Lutfi Tahmaz1, Fikret Erdemir, Yusuf Kibar, Ahmet Cosar, Orhan Yalcýn.   

Abstract

BACKGROUND: Fournier's gangrene (FG) is an extensive fulminant infection of the genitals, perineum or the abdominal wall. The aim of this study is to share our experience with the management of this difficult infectious disease.
METHODS: Thirty-three male patients were admitted to our clinic with the diagnosis of FG between February 1988 and December 2003. The patient's age, etiology and predisposing factors, microbiological findings, duration of hospital stay, treatment, and outcome were analyzed. The patients were divided into two groups. The first 21 patients (Group I) were treated with broad-spectrum triple antimicrobial therapy, broad debridement, exhaustive cleaning, and then they underwent split-thickness skin grafts or delayed closure as needed. The other 12 patients (Group II) were treated with unprocessed honey (20-50 mL daily) and broad-spectrum triple antimicrobial therapy without debridement. Their wounds were cleaned with saline and then dressed with topical unprocessed honey. The wounds were inspected daily and the honey was reapplied after cleaning with normal saline. Then, the patients' scrotum and penis were covered with their own new scrotal skin. The mean age of the patients was 53.9 +/- 9.56 years (range = 23-71).
RESULTS: The source of the gangrene was urinary in 23 patients, cutaneous in seven patients, and perirectal in three patients. The predisposing factors included diabetes mellitus for 11 patients, alcoholism for 10 patients, malnutrition for nine patients, and medical immunosuppression (chemotherapy, steroids, malignancy) for three patients. The mean duration of hospital stay was 41 +/- 10.459 (range = 14-54) days. Two patients in Group I died from severe sepsis. The clinical and cosmetic results were better in Group II than Group I.
CONCLUSION: Necrotizing fasciitis of the perineum and genitalia is a severe condition with a high morbidity and mortality. Traditionally, good management is based on aggressive debridement, broad-spectrum antibiotics, and intensive supportive care but unprocessed honey might revolutionize the treatment of this dreadful disease by reducing its cost, morbidity, and mortality.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16882063     DOI: 10.1111/j.1442-2042.2006.01448.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  21 in total

1.  [Affections of the external genitalia and their management].

Authors:  R Rossi; H Rübben
Journal:  Urologe A       Date:  2010-12       Impact factor: 0.639

2.  Use of a Vacuum-Assisted Device for Fournier's Gangrene: A New Paradigm.

Authors:  Jonathan Silberstein; Julia Grabowski; J Kellog Parsons
Journal:  Rev Urol       Date:  2008

3.  Recent advances in the treatment of necrotizing fasciitis.

Authors:  Marina S Morgan
Journal:  Curr Infect Dis Rep       Date:  2011-10       Impact factor: 3.725

4.  Fournier's Gangrene: A Summary of 10 Years of Clinical Experience.

Authors:  Abdullah Oguz; Metehan Gümüş; Ahmet Turkoglu; Zübeyir Bozdağ; Burak Veli Ülger; Elif Agaçayak; Abdullah Böyük
Journal:  Int Surg       Date:  2015-04-10

5.  Factitious Disorder Presenting with Attempted Simulation of Fournier's Gangrene.

Authors:  Joseph Tseng; Peter Poullos
Journal:  J Radiol Case Rep       Date:  2016-09-30

6.  Fournier's gangrene: an analysis of 80 patients and a novel scoring system.

Authors:  T Yilmazlar; E Ozturk; H Ozguc; I Ercan; H Vuruskan; B Oktay
Journal:  Tech Coloproctol       Date:  2010-06-18       Impact factor: 3.781

Review 7.  Anorectal emergencies: WSES-AAST guidelines.

Authors:  Antonio Tarasconi; Gennaro Perrone; Justin Davies; Raul Coimbra; Ernest Moore; Francesco Azzaroli; Hariscine Abongwa; Belinda De Simone; Gaetano Gallo; Giorgio Rossi; Fikri Abu-Zidan; Vanni Agnoletti; Gianluigi de'Angelis; Nicola de'Angelis; Luca Ansaloni; Gian Luca Baiocchi; Paolo Carcoforo; Marco Ceresoli; Alain Chichom-Mefire; Salomone Di Saverio; Federica Gaiani; Mario Giuffrida; Andreas Hecker; Kenji Inaba; Michael Kelly; Andrew Kirkpatrick; Yoram Kluger; Ari Leppäniemi; Andrey Litvin; Carlos Ordoñez; Vittoria Pattonieri; Andrew Peitzman; Manos Pikoulis; Boris Sakakushev; Massimo Sartelli; Vishal Shelat; Edward Tan; Mario Testini; George Velmahos; Imtiaz Wani; Dieter Weber; Walter Biffl; Federico Coccolini; Fausto Catena
Journal:  World J Emerg Surg       Date:  2021-09-16       Impact factor: 5.469

8.  New insights into the epidemiology and etiology of Fournier's gangrene: a review of 33 patients.

Authors:  R Czymek; P Hildebrand; M Kleemann; U Roblick; M Hoffmann; T Jungbluth; C Bürk; H-P Bruch; P Kujath
Journal:  Infection       Date:  2009-07-23       Impact factor: 3.553

9.  Fournier's gangrene: is the female gender a risk factor?

Authors:  Ralf Czymek; Philine Frank; Stefan Limmer; Andreas Schmidt; Thomas Jungbluth; Uwe Roblick; Conny Bürk; Hans-Peter Bruch; Peter Kujath
Journal:  Langenbecks Arch Surg       Date:  2009-01-13       Impact factor: 3.445

Review 10.  Contemporary diagnosis and management of Fournier's gangrene.

Authors:  Avinash Chennamsetty; Iyad Khourdaji; Frank Burks; Kim A Killinger
Journal:  Ther Adv Urol       Date:  2015-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.